GLP-1 and the Brain: What These Medicines Do (October 2026)

01 · The short answer

What does GLP-1 do in relation to the brain?

GLP-1 medicines help regulate appetite, and appetite is ultimately experienced and controlled through the brain. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

The lived effect is simple. Most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ If you want the wider discussion, our guide on how GLP-1 affects the brain goes deeper into the questions people ask.

02 · Your decision

Is this relevant to you?

It matters if you are deciding whether a GLP-1 medicine suits you and want to understand why it changes hunger. For that decision, the practical points matter more than the neuroscience: how the medicine is licensed, what results look like, and who reviews your treatment.

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.¹ If that fits your situation, you can see the current Mounjaro pen and its starting price. Our weight loss clinic page explains the full process.

Related guide: Glp 1 brain health.

03 · Appetite and fullness

How appetite changes on a GLP-1 medicine

The experience people describe is feeling full sooner and less hungry between meals. That matches the licensed description of how tirzepatide works: it helps regulate appetite and slows how quickly the stomach empties.¹

Two things are happening together. Hormone signalling affects appetite, and slower stomach emptying changes how the body feels after eating. Both support a reduced-calorie diet, which is how the medicine is meant to be used, alongside increased physical activity rather than instead of it.

Tirzepatide's dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹

04 · The blood-brain barrier

What about the blood-brain barrier?

If you want to know whether a GLP-1 medicine reaches the brain directly, ask your prescriber.

If you want to read around the question, our separate page asks whether tirzepatide crosses the blood-brain barrier. Whatever the route, the practical effect you can expect is the one in the licensed description: appetite regulation and a feeling of fullness.

The name of the receptor, the pathway and the region matter to researchers. For someone deciding on treatment, they change nothing about how to take the medicine, what to monitor, or who should review it.

05 · Headlines and rare conditions

News stories about brain conditions

If you see news stories about GLP-1 medicines and brain conditions, the practical steps are the same as for any medicine.

If you develop new symptoms after starting any medicine, tell your prescriber and report them through the Yellow Card scheme.¹⁹ For severe, persistent stomach pain, pain in the upper right abdomen, fever, yellowing of the skin or eyes, or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing, get medical help straight away. Reporting helps regulators spot patterns. Ongoing monthly reviews with the prescribing team are part of treatment with us, including side-effect support, and repeat orders re-check suitability.

Eating well while appetite is lower is also part of safe use. Your prescriber is the right person to discuss diet and nutrition, because that advice depends on your own health and history.

06 · Brain fog and mood

Brain fog, mood and thinking

People often ask whether these medicines clear or cause brain fog. The commonest early effects listed are mild nausea, altered appetite and tiredness in the first days after each injection, and these usually settle.¹

Tiredness and eating less can make anyone feel foggy, so it is reasonable to mention it at a review. Our page on whether GLP-1 helps with brain fog goes through the question in more detail. Brain fog is not listed as a side effect in the UK patient leaflet, but feeling tired is listed as very common (may affect more than 1 in 10 people).¹³

If your mood, sleep or concentration changes noticeably, do not wait for a scheduled review. Contact your prescriber and report it through Yellow Card. If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night.

07 · What results to expect

What the appetite effect adds up to

The appetite effect is useful because of what it allows over time. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, and individual results vary.

Weight loss on Mounjaro is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.¹ Think in months, not days, and judge progress by trend rather than individual weigh-ins.

In trials, weight loss on tirzepatide also came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures.² Those are trial-average secondary outcomes, not promises.

08 · Natural alternatives

"Natural Ozempic" and "poor man's Ozempic"

These nicknames describe supplements marketed as imitations of GLP-1 medicines, berberine being a common example. They are low-cost supplements with no clinical oversight, and dosing is not standardised.

"Natural GLP-1" supplements such as berberine are not medicines, are not regulated for this use and have no comparable trial evidence. Dramatic weight-loss claims from sellers should be treated with suspicion, particularly anyone offering to supply a prescription medicine without a consultation or prescription.

Food, sleep, protein and physical activity genuinely help appetite and weight, and they sit alongside treatment rather than being replaced by it. Their effect varies from person to person.

09 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

10 · Getting treatment

NHS or private access

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment.

With us the route is short. You complete a free online consultation and a GPhC-registered prescriber reviews it; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Supply is official LillyDirect supply, with free next-day tracked delivery in temperature-controlled packaging, and same-day dispatch when ordered by 3pm. We are GPhC-registered, number 9012878. Mounjaro is prescription-only and used alongside a reduced-calorie diet and increased physical activity; this page is information, not medical advice.